ASEAN Journal on Science and Technology for Development
Abstract
Metabolic-associated steatotic liver disease is a metabolic disorder with limited pharmacological treatment options and only one approved medication to date. MASLD can be asymptomatic in its earlier stage and hence, prevention of this disease progression is the most effective approach. Recently, green-synthesized nanoparticles, particularly silver (AgNPs) and gold nanoparticles (AuNPs), have gained interest due to their eco-friendly production, biocompatibility, and bioactive properties. This review highlights the biosynthesis of AgNPs and AuNPs using medicinal plant extracts and their reported biological effects relevant to MASLD management including anti-hyperlipidemic, anti-diabetic, antioxidant and anti-inflammatory activities. While findings are promising, further mechanistic studies and preclinical validation are required to facilitate their use as targeted therapies for MASLD.
Keywords
Green synthesis; Nanoparticles; Metabolic syndrome; Metabolic dysfunction-associated steatotic liver disease.
Publication Date
2025
Received Date
15/05/2025
Revised Date
27/05/2025
Accepted Date
05/06/2025
Recommended Citation
Suhaili, Atiqah; Lim, Ya Chee; Lim, Mei Ann; Lim, Lee Hoon; Khan, Mohammad Mansoob; and Siddique, Monowarul Mobin
(2025)
"Potential of Green Synthesis of Silver and Gold Nanoparticles for the Management of Metabolic Associated Steatotic Liver Disease: A Mini Review,"
ASEAN Journal on Science and Technology for Development: Vol. 43:
No.
1, Article 7.
DOI: https://doi.org/10.61931/2224-9028.1633
Available at:
https://ajstd.ubd.edu.bn/journal/vol43/iss1/7